DuPont Sustiva Launched At 9% Discount To Merck's Crixivan
Executive Summary
AIDS treatment cocktails that use DuPont's non-nucleoside reverse transcriptase inhibitor Sustiva (efavirenz) will be cheaper than those that use Merck's protease inhibitor Crixivan (indinavir), DuPont maintains.